• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS )

    77.74 -3.95 (-4.84%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about GeneDx Holdings Corp. - Class A Common Stock

    < Previous 1 2 Next >
    GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights
    From GeneDx
    Via Business Wire
    Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening
    From GeneDx
    Via Business Wire
    GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns
    From GeneDx
    Via Business Wire
    GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
    From GeneDx
    Via Business Wire
    GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From GeneDx
    Via Business Wire
    GeneDx to Participate in Fall Investor Conferences
    From GeneDx
    Via Business Wire
    GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From GeneDx
    Via Business Wire
    GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients
    From GeneDx
    Via Business Wire
    GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights
    From GeneDx
    Via Business Wire
    GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx to Participate in Upcoming Investor Conferences
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
    The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine 
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx to Participate in 44th Annual Cowen Health Care Conference
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Announces Preliminary 2023 Financial Results
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
    New research from one of the largest exome sequencing studies of patients with epilepsy adds to the mounting evidence that exome sequencing offers superior clinical results compared to multi-gene... 
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Announces Evolution of Executive Leadership Team
    Melanie Duquette joining team as Chief Growth Officer to drive commercial excellence, Jennifer Brendel to take new role as Chief of Corporate Affairs amplifying the GeneDx brand and leadership... 
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced
    From GeneDx Holdings Corp.
    Via GlobeNewswire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.